- Home
- CNTX vs GEOS Comparison
CNTX vs GEOS Comparison
Compare CNTX & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- GEOS
- Stock Information
- Founded
- CNTX 2015
- GEOS 1980
- Country
- CNTX United States
- GEOS United States
- Employees
- CNTX N/A
- GEOS N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- GEOS Industrial Machinery/Components
- Sector
- CNTX Health Care
- GEOS Industrials
- Exchange
- CNTX Nasdaq
- GEOS Nasdaq
- Market Cap
- CNTX 78.0M
- GEOS 72.9M
- IPO Year
- CNTX 2021
- GEOS 1997
- Fundamental
- Price
- CNTX $0.63
- GEOS $13.78
- Analyst Decision
- CNTX Strong Buy
- GEOS
- Analyst Count
- CNTX 5
- GEOS 0
- Target Price
- CNTX $5.50
- GEOS N/A
- AVG Volume (30 Days)
- CNTX 330.3K
- GEOS 474.0K
- Earning Date
- CNTX 08-06-2025
- GEOS 08-07-2025
- Dividend Yield
- CNTX N/A
- GEOS N/A
- EPS Growth
- CNTX N/A
- GEOS N/A
- EPS
- CNTX N/A
- GEOS N/A
- Revenue
- CNTX N/A
- GEOS $116,542,000.00
- Revenue This Year
- CNTX N/A
- GEOS N/A
- Revenue Next Year
- CNTX N/A
- GEOS N/A
- P/E Ratio
- CNTX N/A
- GEOS N/A
- Revenue Growth
- CNTX N/A
- GEOS N/A
- 52 Week Low
- CNTX $0.49
- GEOS $5.51
- 52 Week High
- CNTX $2.75
- GEOS $18.99
- Technical
- Relative Strength Index (RSI)
- CNTX 50.76
- GEOS 64.65
- Support Level
- CNTX $0.62
- GEOS $13.61
- Resistance Level
- CNTX $0.70
- GEOS $17.21
- Average True Range (ATR)
- CNTX 0.05
- GEOS 1.69
- MACD
- CNTX 0.01
- GEOS 0.49
- Stochastic Oscillator
- CNTX 56.44
- GEOS 60.91
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About GEOS Geospace Technologies Corporation (Texas)
Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.